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Available online 27 January 2016Psychotherapy process research examines the content of treatment sessions and their associationwith outcomes
in an attempt to better understand the interactions between therapists and clients, and to elucidatemechanisms
of behavior change. A similar approach is possible in technology-delivered interventions, which have an interac-
tion process that is always perfectly preserved and rigorously deﬁnable. The present study sought to examine the
process of participants' interactionswith a computer-delivered brief intervention for drug use, from a study com-
paring computer- and therapist-delivered brief interventions among adults at two primary health care centers in
New Mexico. Speciﬁcally, we sought to describe the pattern of participants' (N = 178) choices and reactions
throughout the computer-delivered brief intervention, and to examine associations between that process and in-
tervention response at 3-month follow-up. Participants were most likely to choose marijuana as the ﬁrst sub-
stance they wished to discuss (n= 114, 64.0%). Most participants indicated that they had not experienced any
problems as a result of their drug use (n= 108, 60.7%), but nearly a third of these (n= 32, 29.6%) nevertheless
indicated a desire to stop or reduce its use; participants who did report negative consequences were most likely
to endorse ﬁnancial or relationship concerns. However, participant ratings of the importance of change or of the
helpfulness of personalized normed feedback were unrelated to changes in substance use frequency. Design of
future e-interventions should consider emphasizing possible beneﬁts of quitting rather than the negative conse-
quences of drug use, and—when addressing consequences—should consider focusing on the impacts of substance
use on relationship and ﬁnancial aspects. These ﬁndings are an early but important step toward using process
evaluation to optimize e-intervention content.







Computer-delivered behavioral interventions offer their authors a
unique opportunity as well as a unique challenge. In terms of opportu-
nity, they allow creation of an intervention in which every word,
image, branch, color, and sound can be controlled—a stark contrast to
person-delivered interventions in which only speciﬁc principles and
techniques can be codiﬁed. However, this level of control can also be
challenging in its implicit demand on the author to predict the charac-
teristics, reactions, and preferences of future users. Evidence-based
models offer little guidance in regard to such details as what choices
to provide or when to provide them.
Process researchmodels may offer such guidance. These models ex-
amine the content of interactions within intervention sessions, and
compare those process variables with outcomes in an attempt to identi-
fy key mechanisms of change (e.g., Webb et al., 2012; Feeley et al.,a).
. This is an open access article under1999). Describing the choices that participants make in completing
computer-delivered interventions can aid in development of future in-
terventions; for example, being aware of topics that participants rate
as most important can allow for those topics to be emphasized. In
doing so, less salient topics can be avoided, increasing the perceived rel-
evance and “ﬁt” of the intervention. Further, evidence that certain kinds
of in-session ratings are associated with better outcomes—although not
evidence of causation—may provide important clues about possible
mechanisms through which computer-delivered interventions may
exert their effects.
Computer-delivered interventions are also uniquely amenable to
process research. Each choice the participant makes, and the context
in which he or she makes it, is available without the need for arduous
coding of session tapes by raters trained to reliability. Many eHealth in-
terventions also solicit participant ratings of satisfaction with the inter-
vention and/or intention to change within the intervention itself,
providing additional clues as to the user's experience of the intervention
process and further data to compare against outcomes. For example,
user satisfaction is often seen as a critical factor in the efﬁcacy of anthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
12 S.J. Ondersma et al. / Internet Interventions 4 (2016) 11–16intervention, but its actual association with behavioral outcomes is
unclear.
The present study uses a process research framework (e.g., Bertholet
et al., 2014; Rhodes, 2012) to examine participant interactions with a
computer-delivered brief intervention for drug use, from a prior study
comparing computer- and therapist-delivered brief interventions
among adults at two primary health care centers in New Mexico
(Schwartz et al., 2014). We ﬁrst describe the pattern of participants'
choices and reactions throughout the highly interactive computer-
delivered brief intervention. In a subsequent exploratory analysis, we
examine associations between those process variables and intervention
response at a 3-month follow-up.Wewere particularly interested in the
extent to which problem recognition and self-ratings of the importance
of change were associated with actual reductions in substance use at
follow-up.
2. Materials and methods
2.1. Participants
Data for this secondary analysis study are drawn from a clinical trial
comparing computer-delivered to in-person brief interventions among
patients attending one of two primary health care centers in New
Mexico; that trial and all related data collection were approved by the
Institutional Review Boards of the Friends Research Institute and
Christus Health. Participants were adults age 18 and older scoring in
the moderate risk range (between 4 and 26) for illicit drug use on the
Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST;
Humeniuk and Ali, 2006), with self-reported use in the past three
months but no treatment in the past year. All participants were recruit-
ed from the health centers' waiting area by research assistants and re-
ceived $20 for completing the baseline assessment interview. The
present analysis focused on the 178 participants from that trial who
were randomly assigned to and completed the computer-delivered
single-session intervention for substance use. Details regarding the
sample and the results of the clinical trial have been published previous-
ly (Schwartz et al., 2014; Gryczynski et al., 2015). Brieﬂy, the computer-
delivered brief intervention subgroup was primarily White (n = 160,
89.9%) and approximately half female and half of Hispanic ethnicity
(n = 82 for both; 46.1%). Mean age was 36.6 years (SD = 14.8), and
106 (59.6%) were not employed at the time of study enrollment.
2.2. Intervention
Also described in detail in Schwartz et al. (2014), the brief computer-
delivered intervention used in this trial was designed to be highly inter-
active, making use of a talking animated narrator as well as branching
and/or reﬂections in response to participants' choices. Taking approxi-
mately seven minutes to complete, the intervention began by offering
participants a choice of which substance they wished to hear more
about. Participants were then offered personalized, gender-speciﬁc
normed feedback regarding how their use of that substance compared
to adults in the US (using data from the National Survey on Drug Use
and Health); this material emphasized the large proportion of lifetime
users of each drug that had not used it recently (i.e., to convey that ces-
sation of drug use is in fact normative among lifetime drug users). Partic-
ipants were then offered the opportunity to endorse, from a list, which
negative consequences they had personally experienced as a result of
using that substance. Those who endorsed at least one negative conse-
quencewere asked to rate the importance of changing, and—if indicating
moderate or high importance—were helped to consider possible chang-
es. Those who failed to endorse any negative consequences were asked
whether or not they were interested in stopping or reducing their use
of that substance, and were helped with setting change goals, as appro-
priate. All participants were also offered the opportunity to go throughthe intervention a second time, focusing on a different substance. See
Fig. 1 for more detail regarding the structure of the brief intervention.
2.3. Measures
Variables for this analysis were taken from the brief intervention it-
self. Key variables are noted in Fig. 1, and fell into two primary types.
First were basic descriptive variables regarding choices participants
made during the brief intervention. These included which substance
participants chose to discuss, whether or not they endorsed negative
consequences of their substance use, and whether or not they chose to
go through the intervention a second time focusing on a different sub-
stance. The second type consisted of variables that could potentially re-
ﬂect processes through which the brief intervention could have an
effect, including perceptions of the usefulness of the normed feedback,
and responses regarding the importance of changing their use. That is,
evidence of an association between these variables and later substance
use could lead to further research regarding whether interventions fo-
cusing on increasing problem recognition or the perceived relevance
of feedback might lead to better effects.
Outcome was deﬁned primarily in terms of changes in two variables
derived from the ASSIST, which were created by subtracting follow-up
from baseline scores on two keymeasures: (1) the overall ASSIST Global
Continuum of Illicit Drug Risk (GCIDR) score, which captures risk associ-
ated with any drugs the participant reports using and thereby can mea-
sure both polydrug use as well as switching from one drug to another;
and (2) participant responses to ASSIST item 2, which asks about the fre-
quency of substance use in the past three months using a Likert scale
ranging from “Never” to “Daily or Almost Daily.”
2.4. Statistical analysis
The present analyses focused ﬁrst on descriptive statistics regarding
the above-noted process variables, and subsequently on associations
between those process variables and change in drug use frequency/con-
sequences. Regarding the outcome variables, for ASSIST item 2 (drug
use frequency), we created a difference score representing the
participant's baseline and follow-up scores for the substance they
chose to examine ﬁrst (see Fig. 1); thus, this score represented changes
in marijuana use frequency for those who chose marijuana as the ﬁrst
drug to consider, changes in cocaine use frequency for those who
chose to focus on cocaine use ﬁrst, etc. For this outcome variable as
well as for ASSIST GCIDR, the subtraction of the follow-up response
from the baseline response yielded a change score on which a score of
zero indicated no change, a negative score indicated increased use or
overall risk from baseline to follow-up, and a positive score indicated
a reduction in use or overall risk from baseline to follow-up. The
GCIDR change score variable was highly skewed and leptokurtotic,
and could not be rendered normally distributed via transformations; it
was therefore converted to an ordinal variable with ten levels. The
pre-post use frequency variable was also treated as ordinal; outlying
levels with few cases were collapsed, yielding an ordinal variable with
seven levels ranging from−3 to 3.
After characterizing process variables using descriptive statistics, and
after creating the two outcome variables as described above, we subse-
quently examined associations between process variables and the two
ordinal outcome variables using non-parametric statistics (Siegel and
Castellan, 1988): the Mann–Whitney U test (a non-parametric analogue
of the independent values t test, for usewith dichotomouspredictors and
ordinal outcomes) and Kruskal–Wallis one-way analysis of variance (a
non-parametric analogue of a one-way ANOVA, for use with categorical
predictors and ordinal outcomes). Correlations between outcomes and
ratings of the importance of change/satisfaction with feedback (each
being ordinal) were conducted using the Spearman rank-order
correlation.
Fig. 1. Simpliﬁed intervention ﬂow highlighting main branches and key process variables.
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3.1. Participant choices and preferences
The ﬂow of participants during their ﬁrst pass through the interven-
tion is depicted in Fig. 1. (Participants had the choice to go through the
software a second time, focusing on a different substance. Because only
aminority of participants chose a second substance, we report here only
on the results from the ﬁrst pass; however, whether or not participants
opted for a second pass is reﬂected in Fig. 1, and was considered as a
process variable.) When asked which substance they wanted more in-
formation about, most participants (114, 64.0%) chose marijuana; 23
(12.9%) chose opiates, 16 (9.0%) chose cocaine, and 11 (6.2%) chose
amphetamines; less than 8% of participants chose either sedatives, in-
halants, or hallucinogens. Notably, these choices were signiﬁcantly as-
sociated with baseline risk scores on each of these substances, such
that the highest baseline ASSIST risk score was marijuana for partici-
pants who chose marijuana, cocaine for those who chose cocaine, etc.;this pattern was true for all drug classes except for inhalants and seda-
tives, which had a combined sample size of 11 (Table 1).
After receiving personalized normed feedback regarding their chosen
substance, participants were asked to rate the helpfulness of that feed-
back. Overall, just over half of participants (103, or 57.9%) rated it as
somewhat or very helpful, and another 48 (27.0%) rated it as a little help-
ful. Only 27 participants (15.2%) rated it as not at all helpful. Of interest,
ratings of the helpfulness of the normed feedback were unrelated to rat-
ings of the importance of changing (rs = .15, NS), but were associated
with desire to change. Speciﬁcally, 12 of 32 participants (37.5%) who
rated themselves as interested in changing gave the highest possible rat-
ing for the feedback (“very helpful”). In contrast, only 11 of 76 partici-
pants (14.5%) who rated themselves as not interested in changing gave
the highest possible rating of the feedback (χ2[3] = 10.6, p= .014).
When asked to endorse speciﬁc consequences related to their sub-
stance use, a majority (108, or 60.7%) indicated that they were not cur-
rently experiencing any consequences. Of participants who did endorse
negative consequences of their drug use, the most frequently chosen
Table 1
Baseline ASSIST subscale scores as a function of participant choice of intervention focus.
Intervention focus chosen by participant (n) Marijuana Cocaine Amphetamines Inhalants Sedatives Hallucinogens Opiates
Marijuana (114) 11.1 1.0 1.1 0.1 1.1 0.4 1.3
Cocaine (16) 8.4 14.0 0.4 0.3 3.6 0.6 4.4
Amphetamines (11) 8.8 3.1 13.7 1.1 3.2 0.5 6.2
Inhalants (1) 6.0 0.0 0.0 0.0 0.0 0.0 0.0
Sedatives (10) 7.3 2.1 3.9 0.6 5.8 1.1 5.7
Hallucinogens (3) 6.7 2.7 0.0 0.0 0.0 7.7 1.0
Opiates (23) 6.3 1.9 1.2 0.1 2.2 0.3 10.6
Note. Highest ASSIST subscale score in each row is highlighted in bold.
Table 2
Crosstabulation of intervention focus chosen by participantwith positive change in overall
risk and drug use frequency.
Intervention focus
chosen by participant (n)
Positive change
in GCIDR (n, %)
Positive change in drug
use frequency (n, %)
Marijuana (114) 57 (53.8%) 27 (25.5%)
Cocaine (16) 12 (80.0%) 9 (60.0%)
Amphetamines (11) 5 (50.0%) 4 (40.0%)
Inhalants (1) 1 (100%) 0
Sedatives (10) 7 (77.8%) 3 (33.3%)
Hallucinogens (3) 2 (66.7%) 2 (66.7%)
Opiates (23) 15 (75%.0) 10 (50.0%)
14 S.J. Ondersma et al. / Internet Interventions 4 (2016) 11–16consequences were impaired relationships with friends or family (en-
dorsed by 28 participants, 15.7% of the total sample) and money prob-
lems (13 participants, 7.3%). Factors including work, physical health,
emotional problems, legal problems, and other problems (unspeciﬁed)
together were endorsed by 29 participants (16.3%). Baseline ASSIST
scores were signiﬁcantly higher for participants who endorsed a nega-
tive consequence during the intervention (mean ASSIST GCIDR of 42.2
vs. 27.3; t (176) =−5.2, p b .001); the likelihood of endorsing a nega-
tive consequence was 64.7% for participants scoring in the top decile
on the baseline GCIDR, vs. 12.5% for those in the bottom decile.
As indicated in Fig. 1, participants who endorsed a negative conse-
quence of their drug use were asked to rate the importance of changing
their use of the substance they chose to address, using a 0–10 scale. In
addition, participants who did not endorse a negative consequence
but who did indicate a desire to change were also asked to rate the im-
portance of changing. (Of the 108 participants who denied any drug-
related problems, 32 (29.6%) indicated a desire to change their drug
use.) Of the resulting 102 participants asked to rate the importance of
changing (70 who endorsed a drug-related consequence and 32 who
denied any consequences but nevertheless wanted to change), the
mean rating for the importance of change was 4.8 (SD = 3.8); 55.9%
of participants endorsed a score of 5 or lower on this item. Importantly,
this ﬂow only indicates participants' choices their ﬁrst time through the
intervention; as noted in Fig. 1, 45 participants (25.3%) chose to com-
plete the intervention a second time, focusing on a different substance.
3.2. Association of process variables with change in drug use risk, baseline
to 3 month follow-up
As noted, process variables were compared to within-participant
changes in drug use risk between baseline and follow-up, using two
ASSIST-related variables: overall drug use risk (GCIDR) and response
to ASSIST item 2 regarding drug use frequency, using only their re-
sponse for the drug class that they chose to focus on in step one of the
intervention. Most associations were not signiﬁcant (not shown).
There was a signiﬁcant association between participants' initial drug
category selection (dropping the inhalant and hallucinogen categories,
which had 1 and 3 participants respectively) and changes in GCIDR
(Kruskal-Wallis χ2[4] = 10.9, p = .027). A similar difference was
present between participant choice of drug category and changes in
drug use frequency (Kruskal–Wallis χ2[4] = 11.3, p= .024). Post-hoc
pairwise comparisons using the Mann–Whitney U test revealed signiﬁ-
cant differences between participants choosing marijuana and those
choosing cocaine for both GCIDR (U = 434.0, p= .004) and frequency
of use (U = 477.5, p = .008), with greater (more positive) change for
participants choosing cocaine. Pairwise analysis also revealed a speciﬁc
difference between participants choosingmarijuana and those choosing
opiates, for frequency of use only (U = 761.0, p= .034), in which par-
ticipants choosing opiates showed greater (more positive) change than
participants choosing marijuana. Table 2 shows the proportion of par-
ticipants selecting each drug use class who showed positive change in
either use frequency or GCIDR.
There was one additional positive association between process vari-
ables and outcomes. Considering only the 108 participants who deniedany negative consequences as a result of their drug use, those who sub-
sequently chose to make a change in their drug use (n = 32) showed
greater reductions in overall drug use risk (U= 725.5, p= .013). How-
ever, choosing to make a change was not associated with a reduction in
drug use frequency. Other process variables such as problem recogni-
tion, perceived importance of changing, willingness to go through the
intervention a second time, and satisfaction with personalized normed
feedback were unrelated to reductions in drug use risk or frequency at
follow-up.
4. Discussion
Computer-delivered interventions are typically multi-faceted and
can contain many different possible paths, with each path determined
by participants' choices. Greater understanding of those choices—and
how those choicesmight be associatedwith outcomes—can assist in op-
timizing these complex interventions. The present study sought to ex-
plore participants' choices within a highly interactive, primary care-
based brief intervention for drug use, and to examine the extent to
which those choices were associated with short-term outcomes. Over-
all, we found that participants were primarily interested in interacting
with the software with respect to their marijuana use; that most partic-
ipants felt they had not experienced any problems as a result of their
drug use, but that nearly a third of these chose to stop or reduce their
use; and that participants tended strongly to focus on the substance
for which their ASSIST score was highest. Participant ratings of the im-
portance of change or of the helpfulness of personalized normed feed-
back were unrelated to changes in substance use frequency.
Several ﬁndings from this analysis must be highlighted. First, it ap-
pears that non-treatment seeking users of software such as this are like-
ly to make good use of it, even without any guidance from a therapist.
For example, when given the choice to learn more about any type of
drug, participants tended to choose the one that testing suggested was
most problematic for them. This ﬁnding is important given potential
concerns that although allowing participants to choose the focus of
the brief intervention is consistentwithMotivational Interviewing prin-
ciples (Miller and Rollnick, 2013), doing so could allow participants to
avoid the substance that is causing them the most harm. The results of
this analysis suggest that this avoidance of the substance causing the
most risk is unlikely, and that a patient-centered approach to brief inter-
vention seems appropriate. This was even true for marijuana, which
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the chosen focus for themajority of participants. In addition, therewas a
strong linear association between baseline risk scores and the likelihood
that the participant would report that drug use interfered negatively
with his or her life in some way. Finally, even though there was no in-
centive to do so at all (and again, this was a proactively recruited,
non-treatment seeking sample), 25% of participants chose to go through
the program a second time with respect to another substance.
Second, less than half of persons within this non-treatment seeking
sample felt that their substance use was interfering with their lives in
any way, despite the inclusion criteria of active use and at least moder-
ate risk on the ASSIST; further, endorsement of a negative consequence
did not rise above 65%, even among participants with the highest base-
line severity. Further, nearly a third of thosewhodid not perceive signif-
icant negative consequences of their drug use were nevertheless open
to changing their use. This suggests that future interventions should
focus on the beneﬁts of changing and should not presume that a failure
to perceive negative consequences of drug use means that the partici-
pant is not willing to change.
Third, self-reported intention to change was associated with change
in drug use frequency at the three-month follow-up. This ﬁnding mir-
rors that of prior research showing that intention to change is associated
with later behavior change (Webb and Sheeran, 2006). As with other
ﬁndings from this study, it appears that participants' choices in the con-
text of this brief intervention were valid indicators of their risks, the ex-
tent of those risks, and their likelihood of changing. Among other
implications, this suggests that participant-reported intention to change
following a brief intervention may be a valid proxy outcome for use in
pre-post developmental trials (Ondersma et al., 2011).
Finally, it is notable that other process variables such as problem rec-
ognition, perceived importance of changing, willingness to go through
the intervention a second time, and satisfaction with personalized
normed feedback were unrelated to reductions in drug use risk or fre-
quency at follow-up. This lack of association is particularly interesting
in the case of satisfaction with normed feedback, which is a key focus
of usability testing and which is often an important outcome in initial
intervention development (Whittemore et al., 2013; Kim and Chang,
2007; Ondersma et al., 2012; Ondersma et al., 2007). However, the
present ﬁndings are consistent with those from other investigations
ﬁnding no association between satisfaction with the intervention and
behavioral outcome (e.g., Huis in ‘T Veld et al., 2010; Solberg et al.,
2015).
The study has several limitations. First, data were gathered only
from two health center sites in one US state. Findings are limited to
the patient population attending those clinics, and may not generalize
to other patient populations. For example, although individuals with
Hispanic ethnicity were well-represented, the sample included very
few African–American participants. Second, the sample size was not
large, particularly as we considered process variables that were only
available after the sample was repeatedly split as participants
proceeded along the intervention's various branches. Third, ﬁndings
from this study are uniquely tied to the very speciﬁc context of the
brief intervention that was developed under the previous clinical trial
(Schwartz et al., 2014), and may not hold true in the context of another
intervention. Finally, this analysis only considered outcomes at the
three-month follow-up in an effort to maximize our ability to link pro-
cess variables to proximate outcomes. Results may be different when
considering later time points.
5. Conclusions
The present ﬁndings underscore the utility of patient-centered
models of technology-delivered brief intervention. When given the op-
portunity, participants chose to focus on the substances for which their
risk was highest, and—although most chose not to endorse negative
consequences of their drug use—they were more likely to do so whentheir risk was higher. Further, 25% of participants chose to go through
the program a second time in order to focus on a different substance.
This may reﬂect participants' engagement with the brief intervention,
as well as the tendency for persons at moderate risk to be open to
more information about their use.
These ﬁndings also highlight several dimensions relevant to the de-
sign of future computer-delivered brief interventions for drug use. For
example, although fewer than half of this moderate-risk sample report-
ed a speciﬁc negative consequence of their drug use, those who did do
so were most likely to focus on relationships with friends or family
and money problems. Further, nearly a third of those who denied any
negative consequences were nevertheless willing to make a change
when asked. Future interventions should highlight the role of relation-
ship and ﬁnancial issues, and should focusmore on the possible beneﬁts
of changing drug use rather than on perceptions of negative conse-
quences (gain-framed vs. loss-framed messaging; e.g., Mays et al.,
2015). Finally, although self-reported intention to change was associat-
ed with frequency of use at follow-up, a number of other process vari-
ables in the current analysis—including satisfaction with personalized
normed feedback—were unrelated to outcomes. More research is need-
ed to identify in-session tailoring/branching variables that aremost crit-
ical to later outcomes. Such efforts would leverage the unique
transparency of technology-delivered brief interventions to maximize
their efﬁcacy and efﬁciency.Acknowledgements
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